A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy
about
Calcitriol in Combination Therapy for Prostate Cancer: Pharmacokinetic and Pharmacodynamic InteractionsPerspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients' variable responses to 1,25-dihydroxyvitamin d and vitamin d analogsTargeted delivery of 1,25-dihydroxyvitamin D3 to colon tissue and identification of a major 1,25-dihydroxyvitamin D3 glycoside from Solanumglaucophyllum plant leavesCooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemiaCYP24A1 inhibition enhances the antitumor activity of calcitriol.Transcriptional effects of 1,25 dihydroxyvitamin D(3) physiological and supra-physiological concentrations in breast cancer organotypic culture.Vitamin D analogs enhance the anticancer activity of 5-fluorouracil in an in vivo mouse colon cancer modelA phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1α,24(S)Dihydroxyvitamin D2) in patients with advanced cancer.Importance of apical membrane delivery of 1,25-dihydroxyvitamin D3 to vitamin D-responsive gene expression in the colonPKPD modelling to predict altered disposition of 1α,25-dihydroxyvitamin D3 in mice due to dose-dependent regulation of CYP27B1 on synthesis and CYP24A1 on degradation.Pit-1 inhibits BRCA1 and sensitizes human breast tumors to cisplatin and vitamin D treatment.Impact of Short-term 1,25-Dihydroxyvitamin D3 on the Chemopreventive Efficacy of Erlotinib against Oral Cancer.Vitamin D Analogs Potentiate the Antitumor Effect of Imatinib Mesylate in a Human A549 Lung Tumor Model.Vitamin D and cancer: clinical aspects.A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer.Serum vitamin D metabolites in colorectal cancer patients receiving cholecalciferol supplementation: correlation with polymorphisms in the vitamin D genes.In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumorsA phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors.What is the role of vitamin D in autism?26,26,26,27,27,27-Hexadeuterated-1,25-Dihydroxyvitamin D3 (1,25D-d6) As Adjuvant of Chemotherapy in Breast Cancer Cell Lines.Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system.1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer modelsVitamin D in combination cancer treatment.Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.Oral bioavailability of DN101, a concentrated formulation of calcitriol, in tumor-bearing dogs.Vitamin D in prostate cancer.
P2860
Q26766242-1CB6C1DE-C79D-4CDB-AB6B-6462F473A74CQ26991440-6D3BD2F1-2E30-48B3-971E-56711500D95EQ27024755-A163CF8A-7DEF-4BFC-BF2D-77D839456FDCQ33668436-CF913B75-E1AF-4CAD-A134-BBB2F3F83944Q34132307-04AB8C27-95FE-41FF-8715-3D03A3F6E3B2Q34623118-2089E54B-7B11-40FD-9921-C864B14DA834Q34777428-10E11210-464A-43B4-8E16-ABFD67E1E92BQ34799393-0FA8E2E8-BAEB-43CD-BBF4-1266266C6DACQ35141335-5E344EE3-E4F2-41FC-9768-4476B2F985E4Q35865449-A38136BC-C261-4C15-919D-1590BF543BFBQ35987385-724593F5-ED64-4468-9DA0-5D5BEA9A51A4Q36029715-E55E5FAB-24A1-4AB7-BDDF-2A2AE5315010Q36324677-DB5A0ED6-CB5C-4B44-BDBC-C2480F6459E7Q36509508-437CB134-B1F6-47D7-973D-818F943313D1Q36799473-81DE7A30-CD18-4E3D-815D-757E4CE88530Q36946558-7051DF40-2DE0-4F1D-A2B0-24E111E2A139Q37275619-D39AF72D-BDDE-44E7-888B-8C1324EC003DQ37352021-7C59D553-3B89-419C-A194-33F16E0ED42DQ37499956-0C1F7752-8F2C-49A0-A4EB-6C0FFBFFA772Q38672183-9D50A8B9-2A23-4479-9174-F2D2D05D1371Q39668803-2DE89307-C72F-4976-B242-D25187BD8FA1Q39690278-A07CDEDB-6F80-42AB-A869-61FBC40007A6Q42427858-C6436929-CF35-4218-9203-BC5AFCD88324Q42859934-B7D4C7A9-FEBC-4D5E-A4DB-28EBF714D512Q50309039-9EED674F-6CDD-411C-BEEB-6EC40126421AQ55024961-49BAA794-1F99-41AC-9A19-042FB95DF479
P2860
A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A Phase I trial of calcitriol ...... ients with advanced malignancy
@ast
A Phase I trial of calcitriol ...... ients with advanced malignancy
@en
A Phase I trial of calcitriol ...... ients with advanced malignancy
@nl
type
label
A Phase I trial of calcitriol ...... ients with advanced malignancy
@ast
A Phase I trial of calcitriol ...... ients with advanced malignancy
@en
A Phase I trial of calcitriol ...... ients with advanced malignancy
@nl
prefLabel
A Phase I trial of calcitriol ...... ients with advanced malignancy
@ast
A Phase I trial of calcitriol ...... ients with advanced malignancy
@en
A Phase I trial of calcitriol ...... ients with advanced malignancy
@nl
P2093
P1476
A Phase I trial of calcitriol ...... ients with advanced malignancy
@en
P2093
P304
P407
P577
1999-06-01T00:00:00Z